Eczema in the News

August 17, 2015 – The National Eczema Association (NEA) is pleased to share news about a potential new topical non-steroidal treatment for mild-to-moderate eczema that you, the National Eczema Association community, helped make possible.

Read More


August 4, 2015 – The oral Janus kinase inhibitor tofacitinib citrate may be beneficial in the treatment of moderate to severe AD.

Read More


August 3, 2015 – Probiotic supplementation in pregnancy and early infancy can prevent infantile eczema, according to a review and meta-analysis published online July 21 in Allergy.

Read More


July 20, 2015 – Early nutrition and adiposity have been linked to atopic dermatitis (AD) development.

Read More


July 20, 2015 – Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug.

Read More


July 13, 2015 – Anacor Pharmaceuticals Announces Positive Top-Line Results From Two Phase 3 Pivotal Studies of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis.

Read More


June 16,2015 – Dermatologists have long known that available treatments for chronic itch, including eczema, are simply not up to scratch. But scientists have now discovered a new gene that promotes itch, suggesting a way forward for powerful new therapies.

Read More


June 8, 2015 – I have been a part of the eczema community, and the NEA Board of Directors, for many years I never thought I would see the day when hope and opportunity would converge and we would see a promising future for eczema on the horizon. That day is now!

Read More


June 1, 2015 – Patients with either vitiligo, especially early-onset disease, or AA, especially alopecia totalis or alopecia universalis, have significantly increased risk for AD.

Read More


May 29, 2015 – Linalyl acetate, a fragrance chemical that is one of the main constituents of the essential oil of lavender, is not on the list of allergenic compounds pursuant to the EU Cosmetics Directive. Thus, it does not need to be declared on cosmetic products sold within the EU. Recent studies at the University of Gothenburg have shown that linalyl acetate can cause allergic eczema.

Read More